1
|
Medina Gamero A. Challenges and strategies in the prevention of dengue: A challenge for public health. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (ENGLISH ED.) 2024:S2529-993X(24)00109-6. [PMID: 38714419 DOI: 10.1016/j.eimce.2024.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Accepted: 03/11/2024] [Indexed: 05/09/2024]
|
2
|
Ren J, Chen Z, Ling F, Liu Y, Chen E, Shi X, Guo S, Zhang R, Wang Z, Sun J. The epidemiology of Aedes-borne arboviral diseases in Zhejiang, Southeast China: a 20 years population-based surveillance study. Front Public Health 2023; 11:1270781. [PMID: 37942243 PMCID: PMC10629596 DOI: 10.3389/fpubh.2023.1270781] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Accepted: 10/10/2023] [Indexed: 11/10/2023] Open
Abstract
Objective Aedes-borne arboviral diseases were important public health problems in Zhejiang before the coronavirus disease 2019 (COVID-19) pandemic. This study was conducted to investigate the characteristics and change of the epidemiology of Aedes-borne arboviral diseases in the province. Methods Descriptive analyses were conducted to summarize the epidemiology of Aedes-borne arboviral diseases during 2003-2022. Results A total of 3,125 cases, including 1,968 indigenous cases, were reported during 2003-2022. Approximately three-quarters of imported cases were infected from Southeast Asia. The number of annual imported cases increased during 2013-2019 (R2 = 0.801, p = 0.004) and peaked in 2019. When compared with 2003-2012, all prefecture-level cities witnessed an increase in the annual mean incidence of imported cases in 2013-2019 (0.11-0.42 per 100,000 population vs. 0-0.05 per 100,000 population) but a drastic decrease during 2020-2022 (0-0.03 per 100,000 population). The change in geographical distribution was similar, with 33/91 counties during 2003-2012, 86/91 during 2013-2019, and 14/91 during 2020-2022. The annual mean incidence of indigenous cases in 2013-2019 was 7.79 times that in 2003-2012 (0.44 vs. 0.06 per 100,000 population). No indigenous cases were reported between 2020-2022. Geographical extension of indigenous cases was also noted before 2020-from two counties during 2003-2012 to 44 during 2013-2019. Conclusion Dengue, chikungunya fever, zika disease, and yellow fever are not endemic in Zhejiang but will be important public health problems for the province in the post-COVID-19 era.
Collapse
Affiliation(s)
- Jiangping Ren
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
- Key Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Hangzhou, China
- Zhejiang Provincial Station of Emerging Infectious Disease Control and Prevention, Chinese Academy of Medical Sciences, Hangzhou, China
| | - Zhiping Chen
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Feng Ling
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
- Key Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Hangzhou, China
- Zhejiang Provincial Station of Emerging Infectious Disease Control and Prevention, Chinese Academy of Medical Sciences, Hangzhou, China
| | - Ying Liu
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Enfu Chen
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
- Key Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Hangzhou, China
- Zhejiang Provincial Station of Emerging Infectious Disease Control and Prevention, Chinese Academy of Medical Sciences, Hangzhou, China
| | - Xuguang Shi
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Song Guo
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Rong Zhang
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Zhen Wang
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
| | - Jimin Sun
- Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China
- Key Laboratory of Vaccine, Prevention and Control of Infectious Disease of Zhejiang Province, Hangzhou, China
- Zhejiang Provincial Station of Emerging Infectious Disease Control and Prevention, Chinese Academy of Medical Sciences, Hangzhou, China
| |
Collapse
|
3
|
Fernandez-Guzman D, Caira-Chuquineyra B, Calderon-Ramirez PM, Cisneros-Alcca S, Benito-Vargas RM. Sociodemographic factors associated to knowledge and attitudes towards dengue prevention among the Peruvian population: findings from a national survey. BMJ Open 2023; 13:e071236. [PMID: 36944464 PMCID: PMC10032396 DOI: 10.1136/bmjopen-2022-071236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/23/2023] Open
Abstract
OBJECTIVES To evaluate the frequency of knowledge and attitudes towards dengue prevention among the Peruvian population, as well as the sociodemographic factors associated with reported knowledge and attitude outcomes. DESIGN/SETTING A cross-sectional study was conducted, based on information from the National Survey of Budget Programs of Peru, 2019. PARTICIPANTS We included 57 829 respondents with a mean age of 40.3±17.4 years, of whom 52.8% were women and 87.6% were from urban areas. PRIMARY AND SECONDARY OUTCOMES Knowledge about dengue infection (transmission, symptoms, importance of going to a health centre and not self-medicating) and preventive attitudes to avoid infection. RESULTS Of all the respondents, 36.2% (n=23 247) presented good knowledge about dengue and 11.6% (n=7890) had a higher number of preventive attitudes (≥3 attitudes). In the multivariate regression analysis, we found that being female (for knowledge: aPR (adjusted prevalence ratio): 1.03; 95% CI 1.02 to 1.03; and for attitude: aPR: 1.02; 95% CI 1.01 to 1.02), being married/cohabiting (for knowledge: aPR: 1.02; 95% CI 1.00 to 1.03; and for attitude: aPR: 1.01; 95% CI 1.00 to 1.02) and residing in the jungle (for knowledge: aPR: 1.14; 95% CI 1.12 to 1.16; and for attitude: aPR: 1.09; 95% CI 1.07 to 1.11) were associated with better knowledge and more preventive attitudes. In addition, we found that being an adolescent (for knowledge: aPR: 0.97; 95% CI 0.96 to 0.99; and for attitude: aPR: 0.99; 95% CI 0.97 to 0.99), and belonging to the Quechua ethnic group (for knowledge: aPR: 0.93; 95% CI 0.91 to 0.94; and for attitude: aPR: 0.98; 95% CI 0.97 to 0.99) were associated with a lower proportion of adequate knowledge and fewer preventive attitudes. CONCLUSIONS Our study found a high proportion of poor knowledge and few preventive attitudes towards dengue in the Peruvian population. That highlights the requirement to implement national strategies to educate people about dengue and promote preventive attitudes, considering the factors found.
Collapse
Affiliation(s)
| | | | | | - Shanelin Cisneros-Alcca
- Escuela Profesional de Medicina Humana, Universidad Nacional de San Antonio Abad del Cusco, Cusco, Peru
| | - Raysa M Benito-Vargas
- Escuela Profesional de Medicina Humana, Universidad Nacional de San Antonio Abad del Cusco, Cusco, Peru
| |
Collapse
|
4
|
León-Figueroa DA, Abanto-Urbano S, Olarte-Durand M, Nuñez-Lupaca JN, Barboza JJ, Bonilla-Aldana DK, Yrene-Cubas RA, Rodriguez-Morales AJ. COVID-19 and dengue coinfection in Latin America: A systematic review. New Microbes New Infect 2022; 49:101041. [PMID: 36320316 PMCID: PMC9613782 DOI: 10.1016/j.nmni.2022.101041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2022] [Revised: 10/18/2022] [Accepted: 10/20/2022] [Indexed: 11/29/2022] Open
Abstract
Introduction Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread globally, becoming a long-lasting pandemic. Dengue is the most common arboviral disease in tropical and subtropical regions worldwide. COVID-19 and dengue coinfections have been reported, associated with worse outcomes with significant morbidity and mortality. Therefore, this study aims to determine the epidemiological situation of COVID-19 and dengue coinfection in Latin America. Methods A systematic literature review was performed using PubMed, Scopus, Embase, Web of Science, LILACS, and BVS databases from January 1, 2020, to September 4, 2021. The key search terms used were "dengue" and "COVID-19". Results Nineteen published articles were included. The studies were case reports with a detailed description of the coinfection's clinical, laboratory, diagnostic, and treatment features. Conclusion Coinfection with SARS-CoV-2 and dengue virus is associated with worse outcomes with significant morbidity and mortality. The similar clinical and laboratory features of each infection are a challenge in accurately diagnosing and treating cases. Establishing an early diagnosis could be the answer to reducing the estimated significant burden of these conditions.
Collapse
Affiliation(s)
- Darwin A. León-Figueroa
- Facultad de Medicina Humana, Universidad de San Martín de Porres, Chiclayo, Peru
- Unidad de Revisiones Sistemáticas y Meta-análisis, Tau-Relaped Group, Trujillo, Peru
| | - Sebastian Abanto-Urbano
- Sociedad Científica de Estudiantes de Medicina Villarrealinos (SOCEMVI), Lima, Peru
- Facultad de Medicina, Universidad Nacional Federico Villarreal, Lima, Peru
| | - Mely Olarte-Durand
- Facultad de Medicina Humana, Sociedad Científica de Estudiantes de Medicina (SOCEM UPEU), Lima, Peru
- Universidad Peruana Unión, Lima, Peru
| | - Janeth N. Nuñez-Lupaca
- Centro Científico Basadrino de Estudiantes de Medicina (CECIBEM), Tacna, Peru
- Escuela Profesional de Medicina Humana, Universidad Nacional Jorge Basadre Grohmann, Tacna, Peru
| | | | | | - Robinson A. Yrene-Cubas
- Sociedad Científica de Estudiantes de Medicina de la Universidad Científica del Sur (SCIEM UCSUR), Lima, Peru
- Facultad de Medicina Humana, Universidad Científica del Sur, Lima, Peru
| | - Alfonso J. Rodriguez-Morales
- Grupo de Investigación Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, Colombia
- Latin American Network of COVID-19 Research (LANCOVID), Pereira, Risaralda, Colombia
- Clinical Epidemiology and Biostatistics, Universidad Cientifica del Sur, Lima, Peru
| |
Collapse
|
5
|
Khan S, Akbar SMF, Yahiro T, Mahtab MA, Kimitsuki K, Hashimoto T, Nishizono A. Dengue Infections during COVID-19 Period: Reflection of Reality or Elusive Data Due to Effect of Pandemic. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2022; 19:ijerph191710768. [PMID: 36078486 PMCID: PMC9518125 DOI: 10.3390/ijerph191710768] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/11/2022] [Revised: 08/23/2022] [Accepted: 08/23/2022] [Indexed: 05/07/2023]
Abstract
The outbreak of coronavirus disease 2019 (COVID-19) devastated the overall health management strategy of most countries. In this scenario, the present study provided insights into the possible impact of the COVID-19 pandemic on dengue infection. This ecological study retrieved data from WHO/Government reporting system from 22 major dengue epidemic countries. Incidence of dengue infections during the pre-COVID-19 time (2015~2019) and COVID-19 period (2020~2021) was compared. A correlation between the dengue and COVID-19 cases and predicted dengue incidence in 2022 was calculated using the linear regression equation. Data indicated that dengue incidences across the studied area decreased by 16% during the pandemic period (2.73 million vs. 2.29 million; p < 0.05) than the same reported in pre-COVID-19 time. Although countries in Latin America reported more cases than Asia, a positive correlation (r = 0.83) between dengue and COVID-19 cases was observed in Asia. Prediction analysis warned that specific preparation for dengue management is needed in some countries of both regions in 2022 to contain the upsurge in incidences. Due to the similar nature of symptoms of dengue and COVID-19, a state of confusion will be prevailing during the ongoing pandemic. Therefore, comprehensive and evidence-based scientific approaches were warranted at all levels.
Collapse
Affiliation(s)
- Sakirul Khan
- Department of Microbiology, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan
- Correspondence: (S.K.); (A.N.); Tel.: +81-97-586-5712 (S.K. & A.N.); Fax: +81-97-586-5719 (S.K. & A.N.)
| | - Sheikh Mohammad Fazle Akbar
- Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon 791-0295, Ehime, Japan
- Miyakawa Memorial Research Foundation, Tokyo 107-0062, Japan
| | - Takaaki Yahiro
- Department of Microbiology, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan
- Research Center for Global and Local Infectious Diseases, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan
| | - Mamun Al Mahtab
- Division of Interventional Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka 1000, Bangladesh
| | - Kazunori Kimitsuki
- Department of Microbiology, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan
| | - Takehiro Hashimoto
- Department of Microbiology, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan
- Infection Control Center, Oita University Hospital, Yufu 879-5593, Oita, Japan
| | - Akira Nishizono
- Department of Microbiology, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan
- Research Center for Global and Local Infectious Diseases, Faculty of Medicine, Oita University, Yufu 879-5593, Oita, Japan
- Correspondence: (S.K.); (A.N.); Tel.: +81-97-586-5712 (S.K. & A.N.); Fax: +81-97-586-5719 (S.K. & A.N.)
| |
Collapse
|
6
|
Saita S, Maeakhian S, Silawan T. Temporal Variations and Spatial Clusters of Dengue in Thailand: Longitudinal Study before and during the Coronavirus Disease (COVID-19) Pandemic. Trop Med Infect Dis 2022; 7:tropicalmed7080171. [PMID: 36006263 PMCID: PMC9414305 DOI: 10.3390/tropicalmed7080171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 07/31/2022] [Accepted: 08/05/2022] [Indexed: 11/16/2022] Open
Abstract
The efforts towards effective control of the COVID-19 pandemic may affect the incidence of dengue. This study aimed to investigate temporal variations and spatial clusters of dengue in Thailand before and during the COVID-19 pandemic. Reported dengue cases before (2011–2019) and during (2020–2021) the COVID-19 pandemic were obtained from the national disease surveillance datasets. The temporal variations were analyzed using graphics, a seasonal trend decomposition procedure based on Loess, and Poisson regression. A seasonal ARIMA model was used to forecast dengue cases. Spatial clusters were investigated using the local indicators of spatial associations (LISA). The cyclic pattern showed that the greatest peak of dengue cases likely changed from every other year to every two or three years. In terms of seasonality, a notable peak was observed in June before the pandemic, which was delayed by one month (July) during the pandemic. The trend for 2011–2021 was relatively stable but dengue incidence decreased dramatically by 7.05% and 157.80% on average in 2020 and 2021, respectively. The forecasted cases in 2020 were slightly lower than the reported cases (2.63% difference), whereas the forecasted cases in 2021 were much higher than the actual cases (163.19% difference). The LISA map indicated 5 to 13 risk areas or hotspots of dengue before the COVID-19 pandemic compared to only 1 risk area during the pandemic. During the COVID-19 pandemic, dengue incidence sharply decreased and was lower than forecasted, and the spatial clusters were much lower than before the pandemic.
Collapse
Affiliation(s)
- Sayambhu Saita
- Faculty of Public Health, Thammasat University, Lampang 25190, Thailand
- Thammasat University Research Unit in One Health and Ecohealth, Thammasat University, Pathum Thani 12120, Thailand
| | - Sasithan Maeakhian
- Division of Epidemiology, Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand
| | - Tassanee Silawan
- Department of Community Health, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand
- Correspondence: ; Tel.: +66-085-410-2985
| |
Collapse
|
7
|
Wu Q, Dong S, Li X, Yi B, Hu H, Guo Z, Lu J. Effects of COVID-19 Non-Pharmacological Interventions on Dengue Infection: A Systematic Review and Meta-Analysis. Front Cell Infect Microbiol 2022; 12:892508. [PMID: 35663468 PMCID: PMC9162155 DOI: 10.3389/fcimb.2022.892508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Accepted: 04/19/2022] [Indexed: 11/30/2022] Open
Abstract
Non-pharmacological interventions (NPIs) implemented during the coronavirus disease 2019 (COVID-19) pandemic have demonstrated significant positive effects on other communicable diseases. Nevertheless, the response for dengue fever has been mixed. To illustrate the real implications of NPIs on dengue transmission and to determine the effective measures for preventing and controlling dengue, we performed a systematic review and meta-analysis of the available global data to summarize the effects comprehensively. We searched Embase, PubMed, and Web of Science in line with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines from December 31, 2019, to March 30, 2022, for studies of NPI efficacy on dengue infection. We obtained the annual reported dengue cases from highly dengue-endemic countries in 2015–2021 from the European Centre for Disease Prevention and Control to determine the actual change in dengue cases in 2020 and 2021, respectively. A random-effects estimate of the pooled odds was generated with the Mantel-Haenszel method. Between-study heterogeneity was assessed using the inconsistency index (I2) and subgroup analysis according to country (dengue-endemic or non-endemic) was conducted. This review was registered with PROSPERO (CRD42021291487). A total of 17 articles covering 32 countries or regions were included in the review. Meta-analysis estimated a pooled relative risk of 0.39 (95% CI: 0.28–0.55), and subgroup revealed 0.06 (95% CI: 0.02-0.25) and 0.55 (95% CI: 0.44-0.68) in dengue non-endemic areas and dengue-endemic countries, respectively, in 2020. The majority of highly dengue-endemic countries in Asia and Americas reported 0–100% reductions in dengue cases in 2020 compared to previous years, while some countries (4/20) reported a dramatic increase, resulting in an overall increase of 11%. In contrast, there was an obvious reduction in dengue cases in 2021 in almost all countries (18/20) studied, with an overall 40% reduction rate. The overall effectiveness of NPIs on dengue varied with region and time due to multiple factors, but most countries reported significant reductions. Travel-related interventions demonstrated great effectiveness for reducing imported cases of dengue fever. Internal movement restrictions of constantly varying intensity and range are more likely to mitigate the entire level of dengue transmission by reducing the spread of dengue fever between regions within a country, which is useful for developing a more comprehensive and sustainable strategy for preventing and controlling dengue fever in the future.
Collapse
Affiliation(s)
- Qin Wu
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Shuwen Dong
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Xiaokang Li
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Boyang Yi
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Huan Hu
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
| | - Zhongmin Guo
- Sun Yat-Sen College of Medical Science, Sun Yat-sen University, Guangzhou, China
- *Correspondence: Jiahai Lu, ; Zhongmin Guo,
| | - Jiahai Lu
- One Health Center of Excellence for Research and Training, School of Public Health, Sun Yat-sen University, Guangzhou, China
- National Medical Products Administration (NMPA) Key Laboratory for Quality Monitoring and Evaluation of Vaccines and Biological Products, Guangzhou, China
- Key Laboratory of Tropical Diseases Control, Sun Yat-Sen University, Ministry of Education, Guangzhou, China
- Research Institute of Sun Yat-Sen University in Shenzhen, Shenzhen, China
- Hainan Medical University ' One Health' " Research Center, Hainan Medical University, Hainan, China
- *Correspondence: Jiahai Lu, ; Zhongmin Guo,
| |
Collapse
|
8
|
El-Qushayri AE, Kamel AMA, Reda A, Ghozy S. Does dengue and COVID-19 co-infection have worse outcomes? A systematic review of current evidence. Rev Med Virol 2022; 32:e2339. [PMID: 35213764 PMCID: PMC9111070 DOI: 10.1002/rmv.2339] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Revised: 02/01/2022] [Accepted: 02/16/2022] [Indexed: 12/13/2022]
Abstract
In dengue-endemic regions, the co-infection with SARS-CoV-2 and dengue is a significant health concern. Therefore, we performed a literature search for relevant papers in seven databases on 26 Spetember 2021. Out of 24 articles, the mortality rate and intensive care unit (ICU) admission were 19.1% and 7.8%, respectively. The mean hospital stay was 11.4 days. In addition, we identified two pregnancies with dengue and COVID-19 co-infection; one ended with premature rupture of membrane and intrauterine growth restriction fetus, while the other one ended with maternal mortality and intrauterine fetal death. COVID-19 and dengue co-infection had worse outcomes regarding mortality rates, ICU admission, and prolonged hospital stay. Thus, wise-decision management approaches should be adequately offered to these patients to enhance their outcomes. Establishing an early diagnosis might be the answer to reducing the estimated significant burden of these conditions.
Collapse
Affiliation(s)
| | | | - Abdullah Reda
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt
| | - Sherief Ghozy
- Neuroradiology Department, Mayo Clinic, Rochester, Minnesota, USA.,Nuffield Department of Primary Care Health Sciences and Department for Continuing Education (EBHC Program), Oxford University, Oxford, UK
| |
Collapse
|
9
|
Plasencia-Dueñas R, Failoc-Rojas VE, Rodriguez-Morales AJ. Impact of the COVID-19 pandemic on the incidence of dengue fever in Peru. J Med Virol 2021; 94:393-398. [PMID: 34436792 PMCID: PMC8661613 DOI: 10.1002/jmv.27298] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2021] [Revised: 08/03/2021] [Accepted: 08/24/2021] [Indexed: 12/17/2022]
Abstract
Dengue virus and severe acute respiratory syndrome coronavirus 2 coexist in dengue‐endemic countries; therefore, the adoption of preventive measures is essential to control the spread of both viruses. We conducted an ecological study to compare the temporal patterns of the incidence of dengue before and during the Coronavirus disease 2019 (COVID‐19) pandemic in Peru. A time‐series analysis comparing the incidence of dengue using a Student's t test with variance correction was performed. Poisson regression was applied to determine the incidence rate ratio (IRR) of dengue before and during the COVID‐19 pandemic. The incidence of dengue was found to be increased in all endemic regions of Peru during the COVID‐19 pandemic, with the highest incidences registered in Ica (IRR = 90.14), Huánuco (IRR = 38.6), and Ucayali (IRR = 23.78), with the exception of Piura (IRR = 0.83). The highest increases in the number of dengue cases per million inhabitants were in Ucayali (393.38), Tumbes (233.19), Ica (166.08), and Loreto (129.93). The gradient of dengue cases was positive in all endemic regions during the COVID‐19 pandemic. The number of dengue cases per million increased during the COVID‐19 pandemic throughout Peru and in several endemic regions, with the exception of Piura.
Collapse
Affiliation(s)
- Rubí Plasencia-Dueñas
- Sociedad Científica de Estudiantes de Medicina de la Universidad Nacional Pedro Ruiz Gallo, SOCIEM UNPRG, Lambayeque, Peru.,Facultad de Medicina, Universidad Nacional Pedro Ruiz Gallo, Lambayeque, Peru
| | - Virgilio E Failoc-Rojas
- Unidad de Investigación para la Generación y Síntesis de Evidencias en Salud, Universidad San Ignacio de Loyola, Lima, Peru
| | - Alfonso J Rodriguez-Morales
- Grupo de Investigación Biomedicina, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia.,Master of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, Universidad Cientifica del Sur, Lima, Peru
| |
Collapse
|